Skip to main content
PROF logo

PROF · Profound Medical Corp. · Executive Compensation

Track PROF — free
$6.38 -0.21 (-3.19%) At close · Nov 20 Play latest call Q3 2026 earnings call transcript
Market Cap
$233.68M
Shares
36.63M
Volume · Nov 20 144.19K Avg daily vol (3M) 206.49K

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

No Compensation Data

No Summary Compensation Table has been imported from this company's proxy statements yet.

Executive changes

Person Change Filed
Arun Menawat Appointed 2026-11-12
Matthew Sobczyk Appointed 2026-11-12
Richard R. Fabian Appointed 2026-11-12
Jason Mills Appointed 2026-11-12
Cynthia Lavoie
“This resignation was not the result of any disagreement with the Company.”
Resigned 2026-11-12
Richard R. Fabian Appointed 2026-09-03
Rashed Dewan Resigned 2026-08-17
Matthew Sobczyk Appointed 2026-08-17
Frank Baylis Appointed 2026-03-10
Kris Shah
“This resignation was not the result of any disagreement with the Company.”
Resigned 2026-03-10

Leadership

Key facts CIK 1628808 CUSIP 74319B502 13F (30d) 58 filings 55 filers Visit website Investor relations